Università degli Studi dell'Insubria Insubria Space
 

InsubriaSPACE - Thesis PhD Repository >
Insubria Thesis Repository >
01 - Tesi di dottorato >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10277/829

Authors: D'Antona, Paola
Internal Tutor: DOMINIONI, LORENZO
CAMPOMENOSI, PAOLA
Title: Serum miRNAs as biomarkers for early diagnosis of non-small cell lung cancer (NSCLC).
Abstract: Lung cancer is the leading cause of cancer-related deaths worldwide. Late diagnosis, attributable at least partly to the lack of non-invasive screening methods, contributes to its high mortality. Recently, microRNAs (miRNAs) attracted the attention of scientists as possible lung cancer biomarkers since they are stable, retrievable and dysregulated in many types of cancers. We performed a critical review of the literature and selected 8 miRNAs, 4 of which with high sensitivity/AUC and 4 with high specificity. These miRNAs compose a two-step screening: in the first step the high sensitivity miRNAs are measured (miR-223, miR-20a, miR-145, miR-448), whereas in the second step the high specificity miRNAs are measured (miR-210, miR-628-3p, miR-29c, miR-1244). We aimed to identify the two best performing miRNAs. All analyzed miRNAs were expressed at significantly higher levels in NSCLC patients compared to controls. Among the high-sensitivity miRNAs, miR-223 performed best; among high-specificity miRNAs, miR-29c performed best. We then analysed miR-223 and miR-29c to determine the best combination and cut-offs for early lung cancer diagnosis. We measured the levels of miR-223 and miR-29c in a Training set and tested combinations and cut-off values that allowed to obtain the best separation between patients and controls. We found that the formula “miR-223>500 copies/μl OR miR-29c>50 copies/μl” had the highest sensitivity (75%) and acceptable specificity (50%). The formula was then applied to a blind Validation set and we found that it had a very high sensitivity of 92.5%, despite a poor specificity of 37.5%. Our results suggest that our test holds great potential for screening of patients at risk for stage I-II NSCLC.
Keywords: MicroRNAs, biomarkers, lung cancer, NSCLC
Subject MIUR : MED/18 CHIRURGIA GENERALE
Issue Date: 2018
Language: eng
Doctoral course: Biotecnologie, bioscienze e tecnologie chirurgiche
Academic cycle: 31
Publisher: Università degli Studi dell'Insubria
Citation: D'Antona, P.Serum miRNAs as biomarkers for early diagnosis of non-small cell lung cancer (NSCLC). (Doctoral Thesis, Università degli Studi dell'Insubria, 2018).

Files in This Item:

File Description SizeFormatVisibility
PhD_Thesis_DAntonaPaola_completa.pdftesto completo tesi17,63 MBAdobe PDFavailable from: 21/12/2020 View/Open

This item is licensed under a Creative Commons License
Creative Commons


Items in InsubriaSPACE are protected by copyright, with all rights reserved, unless otherwise indicated.


Share this record
Del.icio.us

Citeulike

Connotea

Facebook

Stumble it!

reddit


 

  ICT Support, development & maintenance are provided by the AePIC team @ CILEA. Powered on DSpace Software.  Feedback